INDIANAPOLIS, Oct. 11, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Credit Suisse 2016 Healthcare Conference on Monday, November 7, 2016. The following Lilly executives will participate in a fireside chat at 6:00 p.m., Eastern Time:
- Sue Mahony, Ph.D., senior vice president and president of Lilly Oncology
- Michael Kalos, Ph.D., chief scientific officer, cancer immuno-oncology
- Colleen Mockbee, product team leader, abemaciclib.
A live audio webcast will be available on the “Webcasts & Presentations” section of Lilly’s investor website at http://investor.lilly.com/events.cfm. A replay of the fireside chat will be available for approximately 90 days.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels. F-LLY
Refer to: | Lauren Zierke; lauren_zierke@lilly.com; (317) 277-6524 (Media) |
Phil Johnson; johnson_philip_l@lilly.com; (317) 655-6874 (Investors) |
Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lilly-to-participate-in-credit-suisse-2016-healthcare-conference-300342590.html
SOURCE Eli Lilly and Company
